Joon Cheol Park

Joon Cheol Park

Auto-generated profile, based on publicly available information

Joon Cheol Park

Department of Obstetrics and Gynecology, School of Medicine, Kyungpook National University, Daegu, South Korea; Department of Obstetrics and Gynecology, Kyungpook National University hospital, Daegu, South Korea

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 March 2011 in American Journal of Reproductive Immunology
Verified
Journal Article
Closed access
PDF file
JPJoon-Cheol Park
Joon-Cheol Park
DKDong-Ja Kim
Dong-Ja Kim
JKJoanne Kwak-Kim
Joanne Kwak-Kim

1 January 2016 in Obstetrics & Gynecology Science
Verified
Journal Article
Open access
PDF file
GLGi Su Lee
Gi Su Lee
JPJoon Cheol Park
Joon Cheol Park
JRJeong Ho Rhee
Jeong Ho Rhee
JKJong In Kim
Jong In Kim
Lee GS, et al. Obstet Gynecol Sci. 2016 Sep;59(5):379-387. https://doi.org/10.5468/ogs.2016.59.5.379

1 March 2025 in Clinical and Experimental Reproductive Medicine
Verified
Journal Article
Open access
PDF file
JPJoon Cheol Park
Joon Cheol Park
Objective: Infertility and fertility treatment can lead to considerable physical, emotional, and psychological distress. These effects may be influenced by personality, familial bonds, and support systems within a sociocultural context. This preliminary investigation examined anxiety, depression, and sexual dysfunction in Korean women undergoing in vitro fertilization (IVF)/intracytoplasmic sperm injection (ICSI).Methods: Women scheduled for IVF/ICSI and healthy women seeking general health screening (controls) were enrolled. Participants were asked to complete standardized, validated questionnaires—the Hospital Anxiety and Depression Scale (HADS), Depression Anxiety and Stress Scale (DASS), and Female Sexual Function Index (FSFI)—to assess their levels of anxiety, depression, and sexual function. Results: The mean HADS scores for women undergoing IVF/ICSI were 6.35±3.48 (range, 0 to 13) for anxiety and 8.32±3.78 (range, 2 to 15) for depression. However, 12.9% of the women with infertility experienced clinically significant anxiety (HADS-Anxiety score >11), while 32.3% exhibited depression (HADS-Depression score >11). Based on DASS scores, psychological difficulties were more prevalent among women experiencing infertility than among control participants. Total FSFI scores, along with subscale ratings for desire, arousal, lubrication, satisfaction, and pain, were similar between women with infertility and control women. However, the mean score for orgasm was significantly lower in the infertility group (3.16) than among controls. Age, the durations of marriage and infertility, and parity did not significantly influence HADS, DASS, or FSFI scores.Conclusion: Anxiety and depression were more prevalent among women seeking fertility treatment than among healthy controls. Additionally, women with infertility may experience fewer or diminished orgasms.

1 January 2020 in Yonsei Medical Journal
Verified
Journal Article
Open access
PDF file
DLDong-Yun Lee
Dong-Yun Lee
SLSa Ra Lee
Sa Ra Lee
SKSeul Ki Kim
Seul Ki Kim
JJJongkil Joo
Jongkil Joo
WLWoo Shun Lee
Woo Shun Lee
Sung-Hoon KimSung-Hoon Kim
Sung-Hoon Kim
Lee DY, et al. Yonsei Med J. 2020 Oct;61(10):868-874. https://doi.org/10.3349/ymj.2020.61.10.868

31 July 2021 in Journal of Yeungnam Medical Science
Verified
Journal Article
Open access
PDF file
JPJoon Cheol Park
Joon Cheol Park
DKDong Ja Kim
Dong Ja Kim
Accessory cavitated uterine mass (ACUM) is a rare and unique condition seen in young women. We report cases of ACUMs in two patients, a 14-year-old girl and a 25-year-old woman, both with complaints of severe dysmenorrhea that had started at menarche and had progressively worsened since. A large cystic lesion was localized in the anterolateral wall of the myometrium separate from the endometrium, which was difficult to distinguish from congenital uterine anomalies. Laparoscopic excision of the ACUMs was successful and completely resolved the dysmenorrhea. Early investigation of severe dysmenorrhea in young women can provide appropriate management and relieve symptoms.

1 March 2022 in Clinical and Experimental Reproductive Medicine
Verified
Journal Article
Open access
PDF file
AHAE RA HAN
AE RA HAN
DLDa Yong Lee
Da Yong Lee
SKSeul Ki Kim
Seul Ki Kim
CCChang Woo Choo
Chang Woo Choo
JPJoon Cheol Park
Joon Cheol Park
SKSeok Hyun Kim
Seok Hyun Kim
Humanity is in the midst of the coronavirus disease 2019 (COVID-19) pandemic, and vaccines—including mRNA vaccines—have been developed at an unprecedented speed. It is necessary to develop guidelines for vaccination for people undergoing treatment with assisted reproductive technology (ART) and for pregnancy-related situations based on the extant laboratory and clinical data. COVID-19 vaccines do not appear to adversely affect gametes, embryos, or implantation; therefore, active vaccination is recommended for women or men who are preparing for ART. The use of intravenous immunoglobulin G (IVIG) for the treatment of immune-related infertility is unlikely to impact the effectiveness of the vaccines, so COVID-19 vaccines can be administered around ART cycles in which IVIG is scheduled. Pregnant women have been proven to be at risk of severe maternal and neonatal complications from COVID-19. It does not appear that COVID-19 vaccines harm pregnant women or fetuses; instead, they have been observed to deliver antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to the fetus. Accordingly, it is recommended that pregnant women receive COVID-19 vaccination. There is no rationale for adverse effects, or clinical cases of adverse reactions, in mothers or neonates after COVID-19 vaccination in lactating women. Instead, antibodies to SARS-CoV-2 can be delivered through breast milk. Therefore, breastfeeding mothers should consider vaccination. In summary, active administration of COVID-19 vaccines will help ensure the safe implementation of ART, pregnancy, and breastfeeding.